NA

Nanjappan Aravind

Active Director Managing Director DIN 01895602
DIN 01895602 First appointment Mar 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 5 historical roles
Total affiliations 6 Since Mar 2000
Shareholding value •••• Premium profile

About Nanjappan Aravind

Data last updated:

Nanjappan Aravind is a Managing Director at Kabra Drugs Limited (since 2024). The companies operate in Pharma, Information Technology and Financial Services. Kabra Drugs Limited reported revenue of ₹64 Lakh (FY 2025). Earlier, Nanjappan Aravind was a Managing Director at Crazy Infra & Infomedia Limited (2006–2020) and Director at Nexgen Animators Private Limited (2010–2011) and 3 more.

DIN 01895602
Primary Designation Managing Director
Industry Pharma
First Appointment 01 Mar 2000
Oldest Company Age 37 yrs
Largest company Kabra Drugs Limited · ₹64 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kabra Drugs Limited L02423MP1989PLC005438
Managing Director14 Aug 20241989₹64 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Crazy Infra & Infomedia Limited L14200TN1992PLC084227
Managing Director18 Feb 20061992₹31.86 Cr (FY 2024)Active
Nexgen Animators Private Limited U72900TN2006PTC060302
Director01 Mar 20102006Active
Innovation Software Exports Limited L74999TN1992PLC023734
Director15 Jul 20081992₹58.97 Cr (FY 2024)Active
Agrata Biotech Limited U74999TN2009PLC071298
Managing Director13 Apr 20092009₹17 Lakh (FY 2020)Active
Verna Softech Limited U30006TN1999PLC043363
Managing Director01 Mar 20001999₹66.4 Lakh (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Nanjappan Aravind

NameDINCompanyDesignation
Anand Anitha02040505Kabra Drugs LimitedDirector
Kuniamuthur Nanjappan Anand03230186Kabra Drugs LimitedDirector
Monam Kapoor09278005Kabra Drugs LimitedAdditional Director
Monika Nishant GattaniKabra Drugs LimitedCompany Secretary
Nikita Sinha11126745Kabra Drugs LimitedDirector
PavanasamKabra Drugs LimitedCfo
Ritu Tiwari11040362Kabra Drugs LimitedDirector

Directorship timeline

Open interactive timeline →
Kabra Drugs Limited
Crazy Infra & Infomedia Limited
Nexgen Animators Private Limited
Innovation Software Exports Limited
Premium access

Shareholding and investment profile for Nanjappan Aravind

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nanjappan Aravind

Nanjappan Aravind currently holds 1 directorship: Kabra Drugs Limited (Managing Director, since 14 Aug 2024, revenue ₹64 Lakh (FY 2025)).

Nanjappan Aravind was first appointed on 01 Mar 2000 as Managing Director at Verna Softech Limited. The most recent appointment on record is 14 Aug 2024 at Kabra Drugs Limited.

Nanjappan Aravind held 5 earlier board appointments: Crazy Infra & Infomedia Limited (Managing Director, 18 Feb 2006 to 15 Dec 2020); Nexgen Animators Private Limited (Director, 01 Mar 2010 to 25 Jul 2011); Innovation Software Exports Limited (Director, 15 Jul 2008 to 15 Dec 2020); Agrata Biotech Limited (Managing Director, 13 Apr 2009 to 12 Apr 2014); Verna Softech Limited (Managing Director, 01 Mar 2000 to 15 Mar 2021).

The current boards of Nanjappan Aravind's companies include Anand Anitha (Kabra Drugs Limited), Kuniamuthur Nanjappan Anand (Kabra Drugs Limited), Monam Kapoor (Kabra Drugs Limited), Monika Nishant Gattani (Kabra Drugs Limited), Nikita Sinha (Kabra Drugs Limited), Pavanasam (Kabra Drugs Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available